These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. Felgner JH; Kumar R; Sridhar CN; Wheeler CJ; Tsai YJ; Border R; Ramsey P; Martin M; Felgner PL J Biol Chem; 1994 Jan; 269(4):2550-61. PubMed ID: 8300583 [TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides. Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777 [TBL] [Abstract][Full Text] [Related]
5. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. Miele ME; Bennett CF; Miller BE; Welch DR Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992 [TBL] [Abstract][Full Text] [Related]
6. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Spagnou S; Miller AD; Keller M Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141 [TBL] [Abstract][Full Text] [Related]
7. Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages. De Rosa G; De Stefano D; Laguardia V; Arpicco S; Simeon V; Carnuccio R; Fattal E Eur J Pharm Biopharm; 2008 Sep; 70(1):7-18. PubMed ID: 18482831 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes. Hartmann G; Krug A; Bidlingmaier M; Hacker U; Eigler A; Albrecht R; Strasburger CJ; Endres S J Pharmacol Exp Ther; 1998 May; 285(2):920-8. PubMed ID: 9580645 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. Wang J; Guo X; Xu Y; Barron L; Szoka FC J Med Chem; 1998 Jun; 41(13):2207-15. PubMed ID: 9632353 [TBL] [Abstract][Full Text] [Related]
15. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. Nestle FO; Mitra RS; Bennett CF; Chan H; Nickoloff BJ J Invest Dermatol; 1994 Oct; 103(4):569-75. PubMed ID: 7930684 [TBL] [Abstract][Full Text] [Related]
16. Delivery of antisense oligonucleotides using cholesterol-modified sense dendrimers and cationic lipids. Chaltin P; Margineanu A; Marchand D; Van Aerschot A; Rozenski J; De Schryver F; Herrmann A; Müllen K; Juliano R; Fisher MH; Kang H; De Feyter S; Herdewijn P Bioconjug Chem; 2005; 16(4):827-36. PubMed ID: 16029024 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes. Han M; Chen JL; Hu Y; He CL; Shuai WP; Yu JH; Chen HL; Liang WQ; Mayumi T; Shinsaku N; Gao JQ J Biosci Bioeng; 2008 Sep; 106(3):243-7. PubMed ID: 18929999 [TBL] [Abstract][Full Text] [Related]
18. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review). Hope MJ; Mui B; Ansell S; Ahkong QF Mol Membr Biol; 1998; 15(1):1-14. PubMed ID: 9595549 [TBL] [Abstract][Full Text] [Related]
19. Structural variation of cationic lipids: minimum requirement for improved oligonucleotide delivery into cells. Lindner LH; Brock R; Arndt-Jovin D; Eibl H J Control Release; 2006 Jan; 110(2):444-456. PubMed ID: 16297484 [TBL] [Abstract][Full Text] [Related]